Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpotEvan L. Barrios, Charles C. Caldwell, Michael D. Goodman et al.|JCI Insight|2023Cited by 21
Adverse Long-Term Outcomes and an Immune Suppressed Endotype in Sepsis Patients with Reduced Interferon-γ ELISpot: A Multicenter, Prospective Observational StudyEvan A. Barrios, Charles C. Caldwell, Monty B. Mazer et al.|medRxiv|2023Cited by 4